Skip to main content
. 2016 Jan 8;14:1. doi: 10.1186/s13053-015-0044-z

Table 2.

Distribution of founder mutations of the BRCA1 gene in ovarian cancer patient

Germline mutation All ovarian cancer (n = 125)
5382insC [exon 20] 12/125 (9.6 %)
300 T > G [exon 5] 3/125 (2.4 %)
4153delA [exon 11.17] 2/125 (1.6 %)
All mutations 17/125 (13.6 %)